1. Australia Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Wellfully Limited

Wellfully Limited

WFL.AX
Wellfully LimitedAU flagAustralian Securities Exchange
0.00
AUD
- -
- -
1.48MMarket Cap
Wellfully Limited
WFL.AX
(Australian Securities Exchange)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
FRC
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
- -
- -
0.01
- -
Revenue per Share
-0.03
-0.05
-0.02
-0.01
-0.02
-0.02
-0.03
-0.02
-0.03
-0.05
-0.02
-0.02
-0.03
-0.04
-0.03
-0.02
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.01
-0.01
0.07
0.05
0.03
0.02
0.02
0.01
0.03
-0.01
0.04
0.02
-0.01
0.01
- -
-0.01
Book Value per Share
0.04
0.01
0.09
0.07
0.05
0.05
0.05
0.04
0.07
0.05
0.04
0.02
-0.01
0.01
- -
- -
Tangible Book Value per Share
31
37
58
68
69
70
85
95
104
107
108
109
109
156
239
371
Basic Weighted Avg Shares
1
- -
1
1
1
1
1
1
1
2
1
1
- -
- -
2
2
Sales/Revenue/Turnover
-140.05
-446.66
-144.92
-194.06
-300.15
-209.34
-274.95
-177.43
-377.55
-352.79
-254.22
-253.33
-7,364.15
-1,707.83
-403.59
-431.08
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-1
-2
-1
-1
-1
-1
-2
-2
-4
-6
-2
-2
-4
-6
-7
-6
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-123.34
-426.39
-123.31
-149.25
-271.91
-197.81
-273.38
-168.75
-265.45
-335.49
-160.77
-136.87
-5,562.22
-1,607.78
-348.16
-421.46
Profit Margin (%)
1
- -
5
4
3
3
4
3
7
5
4
2
-2
2
- -
-2
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
1
- -
5
4
3
3
4
4
7
6
4
3
-1
2
1
-2
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-146
- -
- -
-25.64
-56.24
-78.98
-129.86
-164.24
-154.1
- -
- -
-53.98
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-85.74%
-185.33%
-376.02%
Free Cash Flow
- -
- -
228.77%
Net Income, GAAP
30.11%
38.25%
-12.98%
Sales/Revenue/Turnover
89.47%
163.73%
-28.12%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
2
2023
- -
- -
- -
- -
2

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
-0.04
2022
- -
- -
- -
- -
-0.03
2023
- -
- -
- -
- -
-0.02

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Health S.A. (MLAHC.PA)
CardioGenics Holdings Inc (CGNH)
BioPorto A/S (THOXF)
Fulgent Genetics, Inc. (FLGT)
Labcorp Holdings Inc. (0JSY.L)
Maccura Biotechnology Co.Ltd (300463.SZ)
Business
Wellfully Limited (ASX:WFL), a science-based wellness company founded in 1992 and headquartered in Leederville, Western Australia, engages in the research, development and commercialization of Dermaportation and Enhanced Transdermal Polymer (ETP) transdermal drug delivery technologies; it operates through segments including Dermaportation Drug Delivery Technology and Devices, with brands such as REDUIT for technology-enhanced skincare and haircare treatments featuring ultrasonic diffusion and magnetic mist applicators like the RÉDUIT One device and Hairpods, and SWISSWELL for related wellness products; the company provides industrialization, supply-chain support, direct-to-consumer marketing, business-to-business collaborations, and third-party partnerships serving pharmaceutical, cosmetic, skincare and consumer healthcare sectors across Australia, Switzerland via Wellfully SA, and international markets. Wellfully targets precise active ingredient delivery in haircare, skincare, medical treatments and surface applications using patented Magnetic Misting, Permanent Magnetic, Electromagnetic and Programmable Array technologies. In recent developments, the company entered administration in August 2023 with Bryan Hughes and Christopher Pattinson of Pitcher Partners appointed as administrators, followed by multiple adjournments of creditor meetings through 2024 amid asset sale interests and recapitalization efforts including a non-binding MOU with The Brandbase in late 2022 that ceased in 2023, a $1.5 million capital raise via placements in April 2023, debt conversions involving related parties, and organizational restructuring for cost reduction; further administrations occurred in October 2024 with Clifford Rocke and Jimmy Trpcevski of WA Insolvency Solutions, culminating in liquidation appointment on November 27, 2024, and delisting from the ASX on July 31, 2025 under Listing Rule 17.12 due to prolonged trading suspension exceeding two years.